Oxford Covid Vaccine Trials To Be Conducted In India Soon; Other Big Stories
Updated: July 21, 2020 07:33 IST
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK. The vaccine AZD1222 had a favourable response in the first phase of clinical trials. It did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
A vaccine for Covid-19 developed by Oxford University and AstraZeneca was safe and produced an immune response in early-stage clinical trials, data showed on Monday, raising hopes that the world could soon find a way to stop the virus that has taken an unprecedented human and economic toll across the planet. Hindustan Times
Officials of the Union health ministry had in early April blocked public disclosure of the names of 36 districts where researchers had found evidence of community transmission of the new coronavirus, three experts guiding India's pandemic response have said. The Telegraph
A special CBI court on Monday set July 24 for recording the statement of former deputy prime minister L K Advani in the Babri mosque demolition case. His statement under section 313 of CrPC will be recorded through video conferencing. Asian Age
